Synarel (G.D. Searle LLC Division of Pfizer Inc)


Welcome to the PulseAid listing for the Synarel drug offered from G.D. Searle LLC Division of Pfizer Inc. This Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: G.D. Searle LLC Division of Pfizer Inc
NON-PROPRIETARY NAME: nafarelin acetate
SUBSTANCE NAME: NAFARELIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-02-13
END MARKETING DATE: 0000-00-00


Synarel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSynarel from G.D. Searle LLC Division of Pfizer Inc
LABELER NAME: G.D. Searle LLC Division of Pfizer Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 1990-02-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0025-0166_34a25b9f-0e93-4436-9bda-4283b0e43d5f
PRODUCT NDC: 0025-0166
APPLICATION NUMBER: NDA019886

Other NAFARELIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
G.D. Searle LLC Division of Pfizer IncSynarel
Neolpharma, Inc.Synarel